Skip to main content
Top
Published in: Hepatology International 2/2009

01-06-2009 | Case Report

Two cases of hepatocellular adenomatosis treated with transcatheter arterial embolization

Authors: Sawako Kobayashi, Hiroki Sakaguchi, Masaki Takatsuka, Takehisa Suekane, Shuji Iwai, Hiroyasu Morikawa, Masaru Enomoto, Akihiro Tamori, Norifumi Kawada

Published in: Hepatology International | Issue 2/2009

Login to get access

Abstract

Hepatocellular adenoma is a rare benign tumor of the liver. However, some complications, such as hemorrhage, rupture, and malignant transformation, have been reported previously. Surgical resection is considered to be the best choice of treatment, when adenomas are increasing in size, while resection is difficult to perform when multiple adenomas develop throughout the liver. Here, we report two cases of multiple hepatocellular adenomatosis. One patient had a history of aplastic anemia and the other had glycogen storage disease. We treated them with transcatheter arterial embolization (TAE) to prevent hemorrhage and rupture. After TAE, most parts of the adenomas showed necrotic change. These cases suggest that TAE is an effective treatment of hepatocellular adenomatosis.
Literature
1.
go back to reference Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, et al. Epidemiology of the hepatocellular adenoma: the role of oral contraceptive use. JAMA 1979;242:644–648PubMedCrossRef Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, et al. Epidemiology of the hepatocellular adenoma: the role of oral contraceptive use. JAMA 1979;242:644–648PubMedCrossRef
2.
go back to reference Kerlin P, Davis GL, McGill DB, Weiland LH, Adson MA, Sheedy PFII. Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic and radiologic features. Gastroenterology 1983;84:994–1002PubMed Kerlin P, Davis GL, McGill DB, Weiland LH, Adson MA, Sheedy PFII. Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic and radiologic features. Gastroenterology 1983;84:994–1002PubMed
3.
go back to reference Bühler H, Pirovino M, Akobiantz A, Altorfer J, Weitzel M, Maranta E, et al. Regression of liver cell adenoma. A follow-up study of three consecutive patients after discontinuation of oral contraceptive use. Gastroenterology 1982;82:775–782PubMed Bühler H, Pirovino M, Akobiantz A, Altorfer J, Weitzel M, Maranta E, et al. Regression of liver cell adenoma. A follow-up study of three consecutive patients after discontinuation of oral contraceptive use. Gastroenterology 1982;82:775–782PubMed
4.
go back to reference Brophy CM, Bock JF, West AB, McKhann CF. Liver cell adenoma: diagnosis and treatment of a rare hepatic neoplastic process. Am J Gastroenterol 1989;84:429–432PubMed Brophy CM, Bock JF, West AB, McKhann CF. Liver cell adenoma: diagnosis and treatment of a rare hepatic neoplastic process. Am J Gastroenterol 1989;84:429–432PubMed
7.
go back to reference Volmar KE, Burchette JL, Creager AJ. Hepatic adenomatosis in glycogen storage disease type Ia: report of a case with unusual histology. Arch Pathol Lab Med 2003;127:e402–e405PubMed Volmar KE, Burchette JL, Creager AJ. Hepatic adenomatosis in glycogen storage disease type Ia: report of a case with unusual histology. Arch Pathol Lab Med 2003;127:e402–e405PubMed
8.
go back to reference Flejou JF, Barge J, Menu Y, Degott C, Bismuth H, Potet F, et al. Liver adenomatosis. An entity distinct from liver adenoma? Gastroenterology 1985;89:1132–1138PubMed Flejou JF, Barge J, Menu Y, Degott C, Bismuth H, Potet F, et al. Liver adenomatosis. An entity distinct from liver adenoma? Gastroenterology 1985;89:1132–1138PubMed
9.
go back to reference Chiche L, Dao T, Salamé E, Galais MP, Bouvard N, Schmutz G, et al. Liver adenomatosis: reappraisal, diagnosis, and surgical management: eight new cases and review of the literature. Ann Surg 2000;231:74–81PubMedCrossRef Chiche L, Dao T, Salamé E, Galais MP, Bouvard N, Schmutz G, et al. Liver adenomatosis: reappraisal, diagnosis, and surgical management: eight new cases and review of the literature. Ann Surg 2000;231:74–81PubMedCrossRef
10.
go back to reference Fulcher AS, Sterling RK. Hepatic neoplasms: computed tomography and magnetic resonance features. J Clin Gastroenterol 2002;34:463–471PubMedCrossRef Fulcher AS, Sterling RK. Hepatic neoplasms: computed tomography and magnetic resonance features. J Clin Gastroenterol 2002;34:463–471PubMedCrossRef
11.
go back to reference Ribeiro A, Burgart LJ, Nagorney DM, Gores GJ. Management of liver adenomatosis: results with a conservative surgical approach. Liver Transpl Surg 1998;4:388–398PubMedCrossRef Ribeiro A, Burgart LJ, Nagorney DM, Gores GJ. Management of liver adenomatosis: results with a conservative surgical approach. Liver Transpl Surg 1998;4:388–398PubMedCrossRef
12.
go back to reference Talente GM, Coleman RA, Alter C, Baker L, Brown BI, Cannon RA, et al. Glycogen storage disease in adults. Ann Intern Med 1994;120:218–226PubMed Talente GM, Coleman RA, Alter C, Baker L, Brown BI, Cannon RA, et al. Glycogen storage disease in adults. Ann Intern Med 1994;120:218–226PubMed
13.
go back to reference Grazioli L, Federle MP, Ichikawa T, Balzano E, Nalesnik M, Madariaga J. Liver adenomatosis: clinical, histopathologic, and imaging findings in 15 patients. Radiology 2000;216:395–402PubMed Grazioli L, Federle MP, Ichikawa T, Balzano E, Nalesnik M, Madariaga J. Liver adenomatosis: clinical, histopathologic, and imaging findings in 15 patients. Radiology 2000;216:395–402PubMed
14.
go back to reference Kebapci M, Kaya T, Aslan O, Bor O, Entok E. Hepatic adenomatosis: gadolinium-enhanced dynamic MR findings. Abdom Imaging 2001;26:264–268PubMedCrossRef Kebapci M, Kaya T, Aslan O, Bor O, Entok E. Hepatic adenomatosis: gadolinium-enhanced dynamic MR findings. Abdom Imaging 2001;26:264–268PubMedCrossRef
15.
go back to reference Ault GT, Wren SM, Ralls PW, Reynolds TB, Stain SC. Selective management of hepatic adenomas. Am Surg 1996;62:825–829PubMed Ault GT, Wren SM, Ralls PW, Reynolds TB, Stain SC. Selective management of hepatic adenomas. Am Surg 1996;62:825–829PubMed
16.
go back to reference Leese T, Farges O, Bismuth H. Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit. Ann Surg 1988;208:558–564PubMedCrossRef Leese T, Farges O, Bismuth H. Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit. Ann Surg 1988;208:558–564PubMedCrossRef
17.
go back to reference Luigi G, Federle MP, Brancatelli G, Ichikawa T, Olivetti L, Blachar A. Hepatic adenomas: imaging and pathologic findings. RadioGraphics 2001;21:877–892 Luigi G, Federle MP, Brancatelli G, Ichikawa T, Olivetti L, Blachar A. Hepatic adenomas: imaging and pathologic findings. RadioGraphics 2001;21:877–892
18.
go back to reference Hsu CY, Chu CH, Lin SC, Yang FS, Yang TL, Chang KM. Concomitant hepatocellular adenoma and adenomatous hyperplasia in a patient without cirrhosis. World J Gastroenterol 2003;9:627–630PubMed Hsu CY, Chu CH, Lin SC, Yang FS, Yang TL, Chang KM. Concomitant hepatocellular adenoma and adenomatous hyperplasia in a patient without cirrhosis. World J Gastroenterol 2003;9:627–630PubMed
Metadata
Title
Two cases of hepatocellular adenomatosis treated with transcatheter arterial embolization
Authors
Sawako Kobayashi
Hiroki Sakaguchi
Masaki Takatsuka
Takehisa Suekane
Shuji Iwai
Hiroyasu Morikawa
Masaru Enomoto
Akihiro Tamori
Norifumi Kawada
Publication date
01-06-2009
Publisher
Springer-Verlag
Published in
Hepatology International / Issue 2/2009
Print ISSN: 1936-0533
Electronic ISSN: 1936-0541
DOI
https://doi.org/10.1007/s12072-009-9126-1

Other articles of this Issue 2/2009

Hepatology International 2/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.